Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
3.590
-0.040 (-1.10%)
At close: Oct 30, 2026, 4:00 PM EDT
3.630
+0.040 (1.11%)
After-hours: Oct 30, 2026, 7:51 PM EDT
Wave Life Sciences Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, Wave Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $17.11. The average 1-year stock price forecast is 376.60% higher than the current stock price, while the lowest is $10 (+178.55%) and the highest is $44 (+1,125.63%).
Price Target: $17.11 (+376.60%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 14 | 17 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 18 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $42 → $44 | Buy | Reiterates | $42 → $44 | +1,125.63% | Oct 29, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $22 | Buy | Maintains | $22 | +512.81% | Oct 29, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $32 → $29 | Buy | Maintains | $32 → $29 | +707.80% | Oct 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $13 | Buy | Maintains | $13 | +262.12% | Oct 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $15 | Buy | Maintains | $15 | +317.83% | Oct 28, 2026 |
Financial Forecast
Revenue This Year
62.57M
from 42.73M
Increased by 46.45%
Revenue Next Year
34.16M
from 62.57M
Decreased by -45.41%
EPS This Year
-1.11
from -1.21
EPS Next Year
-1.16
from -1.11
EPS and Forward PE are based on non-GAAP adjusted numbers.